CSC Sees Q4 Adjusted EPS of $0.19-0.21

CSC

today provided a preliminary and unaudited update for the fourth quarter and the full fiscal year 2012, ended March 30, 2012. On December 27, 2011, the Company announced a material impairment of its net investment in the UK National Health Service (

) contract and at the same time, withdrew its guidance for its fiscal year 2012. Given the uncertainty surrounding the future of the NHS contract, the Company was not in a position to reasonably estimate fiscal 2012 financial performance. The preliminary and unaudited Q4 update is as follows: Revenue: $4.1B Adjusted EPS $0.19-0.21